Daniel R. Passeri
CHIEF EXECUTIVE OFFICER · Cue Biopharma, Inc.
IndividualBuying only
- 2024
- Dec 18, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel R. Passeri files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.91M in CUE purchases and sales in the last 12 months
- Sumita Ray - $317K in CUE purchases and sales in the last 12 months
- Michael Vincent Meluzio - $201K in CUE purchases and sales in the last 12 months
- Pasha Sarraf - $100K in CUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel R. Passeri?
Daniel R. Passeri is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Daniel R. Passeri last file a Form 4?
The only primary Form 4 on record is dated 18 December 2024.
Has Daniel R. Passeri been buying or selling stock?
Recorded transactions: 1 open-market purchase ($31K) and 0 open-market sales across all tracked filings.
